Clinical trial seeks participants
A clinical research study is recruiting local participants who have schizophrenia or schizoaffective disorder, and who are also experiencing involuntary movements in the face and other parts of the body. The Kinect study will investigate the safety and effectiveness of an investigational oral medication for a condition known as tardive dyskinesia. The neurological disorder can be brought on after the long-term or high-dosage use of antipsychotic drugs that can be prescribed for those who suffer from schizophrenia or schizoaffective disorder. Tardive dyskinesia results in involuntary, repetitive movements. Those between the ages of 18 and 85 who are experiencing involuntary movements in their face or other parts of their body and suffer from schizophrenia or schizoaffective disorder are invited to see if they qualify for the study. Each individual will be evaluated and those who qualify will receive study medication, study-related medical exams, and lab tests at no charge. More information about the trial is available at www.kinectstudy.com.